Immunotherapy linked to lower risk of Alzheimer's disease

IVIg treatments, the addition of good antibodies into the blood stream, may hold promise for lowering the risk of Alzheimer's disease and other similar brain disorders, according to research published in the 21 July print issue of Neurology(R), the medical journal of the American Academy of Neurology...

Read the whole article on

More from